about
FOXRED1, encoding an FAD-dependent oxidoreductase complex-I-specific molecular chaperone, is mutated in infantile-onset mitochondrial encephalopathyProgress and prospects for engineered T cell therapiesSignal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fissionAllogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiencyLong-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studySleeping beauty transposition from nonintegrating lentivirus.Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiencyGenome-Edited T Cell Therapies.Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleasesEx-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin graftsComparison of lentiviral and sleeping beauty mediated αβ T cell receptor gene transfer.Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene.Astrovirus VA1/HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patientsAdoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015.Human involucrin promoter mediates repression-resistant and compartment-specific LEKTI expressionGene therapy for severe combined immune deficiency.Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.Update on clinical gene therapy in childhood.Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis.Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.Hybrid lentiviral vectors.Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.Gene therapy for primary immunodeficiencies: current status and future prospects.Gene therapies for inherited skin disorders.Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy.Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant.Engineered T cell therapies.Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.T-cell receptor αβ+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency.Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG / NEMO mutations.Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells.Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency.Manufacture of GMP-compliant functional adenovirus-specific T-cell therapy for treatment of post-transplant infectious complications.Effect of stem cell source on long-term chimerism and event-free survival in children with primary immunodeficiency disorders after fludarabine and melphalan conditioning regimen.T cell transduction and suicide with an enhanced mutant thymidine kinase.
P50
Q24300457-EF5BB94F-1B3E-4E70-BDFA-9C2E313DF59CQ26852923-DE1DD23B-0625-4C57-B610-8DCD2848EB52Q28115520-72BCC677-947B-4680-9C50-4717D9B3D9ABQ28236907-D97D850C-8DFE-4FB0-B26B-FF8BF936885AQ33395718-843EC646-1E93-443A-A89B-D6B38B393BC2Q33713788-4921827F-2EEC-47C0-915B-113070D7951DQ33722772-8D35CABC-CA2A-4CB8-98E0-AE930450362AQ33729598-E1666904-5B34-4D2B-9ECD-C832F28635D0Q34200828-B54BBFF8-EB4A-420A-A8F2-82795FC5F93FQ34556821-927F6493-CB03-42A6-93E8-A472FF22FAC2Q34808631-600FF097-4E6F-46D2-96D1-070487C750D4Q35035023-02DC3916-1FD6-444E-B4A6-219535407206Q35135487-AD7B75ED-2B54-47EC-A7FB-C10F37724700Q35641721-72735BCA-E9EC-4016-AF98-7DBAB11EB624Q35678420-F6613F3A-F234-4434-BB28-131E2219BF44Q35827479-B156CD40-E0C3-437F-9796-ABF27720E53BQ36401357-257FB55C-42AD-47B6-9423-A718D667A502Q36595683-D8876546-31D6-49FC-8006-3EBE6AA59868Q36978568-F0D5295E-96B8-4199-A522-D7F51647F9BAQ37316282-53A69537-A638-40C6-875A-ED06CAE9B490Q37553441-38F128D2-18EC-45F8-B302-9CCC176A2A85Q37566736-4FE8A773-1F76-45CD-BCE3-9710F00E6B31Q37734854-F450BBBB-3B6C-49D4-8AF6-A032B866A0E0Q37888109-647E9397-A671-4295-9077-550E63FC73FFQ38213501-678F5C67-33A6-4E59-98FE-8CC33096EC85Q38236195-A19E2A13-DCBD-4338-99C7-C22C333616E0Q38379085-C8BFBB90-E45F-4598-BDE3-5FDD67161605Q38498978-5A267AC6-9289-4A29-8142-0169269CD4F1Q38623827-9CED2192-7647-4BE8-87C1-9DE62D26D94FQ38718016-16D7F42F-FDFD-421C-9F0D-FAAA44689D71Q39971923-B8C93BDC-7F7C-4D55-831D-D0D7F1F612D9Q40081805-563A9684-CFC1-4564-9B10-2967B593E25DQ40093523-CC7DB209-75E7-4E9D-B923-9DF1C1486C47Q40146597-72B0FE70-70F7-4E53-8AE5-43CD45C33BB1Q40397520-DE7FE56B-EF20-43D3-A842-DF90D8D7B043Q40449833-116CA6F0-92AC-4457-8253-2A0A37B5825AQ40576885-CE2F373E-0776-423F-BE9F-9FC0FF0F16EDQ40611065-8EE9731A-5635-45F4-BD9B-935FF6785891Q40727931-EF42E5FC-86E4-428A-9C3C-390EBF9ACF84Q40728110-88819C9D-D865-4082-A53B-5D80D7010B55
P50
description
researcher ORCID ID = 0000-0001-8353-4494
@en
wetenschapper
@nl
name
Waseem Qasim
@ast
Waseem Qasim
@en
Waseem Qasim
@es
Waseem Qasim
@nl
type
label
Waseem Qasim
@ast
Waseem Qasim
@en
Waseem Qasim
@es
Waseem Qasim
@nl
prefLabel
Waseem Qasim
@ast
Waseem Qasim
@en
Waseem Qasim
@es
Waseem Qasim
@nl
P21
P31
P496
0000-0001-8353-4494